Effects of lead and mercury on the blood proteome of children

Journal of Proteome Research

Volumn 9, Issue 9, 2010, Pages 4443-4453

  Birdsall, Robert E ^a   Kiley, Michael P ^a   Segu, Zaneer M ^b   Palmer, Christopher D ^c   Madera, Milan ^b   Gump, Brooks B ^a   MacKenzie, James A ^a   Parsons, Patrick J ^c,d   Mechref, Yehia ^b   Novotny, Milos V ^b   Bendinskas, Kestutis G ^b  

^a STATE UNIVERSITY OF NEW YORK AT OSWEGO   (United States)

^b INDIANA UNIVERSITY   (United States)

^c WADSWORTH CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

ApoE; apolipoprotein E; cardiovascular; children, blood; Hg; lead; mercury; Pb; proteomics

Indexed keywords

APOLIPOPROTEIN E; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; GELSOLIN; LEAD; MERCURY; N ACETYLMURAMOYLALANINE AMIDASE; PROTEOME; VITRONECTIN;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; BLOOD SAMPLING; CHILD; FEMALE; GENOTYPE; HUMAN; LEAD BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEOMICS; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; APOLIPOPROTEINS E; BLOOD PROTEINS; BLOTTING, WESTERN; CHILD; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LEAD POISONING; MALE; MERCURY POISONING; PEPTIDE FRAGMENTS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; SOCIOECONOMIC FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 77956336164     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100204g     Document Type: Article

References (89)

1. Annette Prus-Ustun, L. F., Philip J. Landrigan, and Jose Luis Ayuso-Mateos Global and Regional Burden of Diseases Attributable to Selected Major Risk Factors; Chapter 19. Lead exposure. http://www.who.int/publications/ cra/chapters/volume2/1495-1542.pdf (accessed 01/19/2010).
2. WHO Chapter 6.7 Lead; Air Quality Guidelines. www.euro.who.int/document/ aiq/6-7lead.pdf (accessed 01/19/2010).
3. WHO Chapter 6.9 Mercury; Air Quality Guidelines www.euro.who.int/ document/aiq/6-9mercury.pdf (accessed 01/19/2010).
4. White, L. D.; Cory-Slechta, D. A.; Gilbert, M. E.; Tiffany-Castiglioni, E.; Zawia, N. H.; Virgolini, M.; Rossi-George, A.; Lasley, S. M.; Qian, Y. C.; Basha, M. R. New and evolving concepts in the neurotoxicology of lead Toxicol. Appl. Pharmacol. 2007, 225 (1) 1-27
5. Ekong, E. B.; Jaar, B. G.; Weaver, V. M. Lead-related nephrotoxicity: a review of the epidemiologic evidence Kidney Int 2006, 70 (12) 2074-84
6. Mudipalli, A. Lead hepatotoxicity & potential health effects Indian J Med Res 2007, 126 (6) 518-27
7. Menke, A.; Muntner, P.; Batuman, V.; Silbergeld, E.; Guallar, E. Blood Lead Below 0.48 μmol/L (10 μg/dL) and Mortality Among US Adults Circulation 2006, 114, 1388-1394
8. Needleman, H. L.; Schell, A.; Bellinger, D.; Leviton, A.; Allred, E. N. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report N Engl J Med 1990, 322 (2) 83-8
9. Gump, B. B.; Reihman, J.; Stewart, P.; Lonky, E.; Darvill, T.; Matthews, K. A. Blood Lead (Pb) Levels: A Potential Environmental Mechanism Explaining the Relation Between Socioeconomic Status and Cardiovascular Reactivity in Children Health Psychol. 2007, 26 (3) 296-304
10. Gump, B. B.; Reihman, J.; Stewart, P.; Lonky, E.; Darvill, T.; Matthews, K. A.; Parson, P. J. Prenatal and early childhood blood lead levels and cardiovascular functioning in 9 1/2 year old children Neurotoxicology and Teratology 2005, 27, 655-665
11. Nawrot, T. S.; Staessen, J. A. Low-level environmental exposure to lead unmasked as silent killer Circulation 2006, 114 (13) 1347-9
12. Muntner, P.; Menke, A.; DeSalvo, K. B.; Rabito, F. A.; Batuman, V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys Arch Intern Med 2005, 165 (18) 2155-61
13. Flegal, A. R.; Smith, D. R. Lead levels in preindustrial humans N Engl J Med 1992, 326 (19) 1293-4
14. Holmes, P.; James, K. A.; Levy, L. S. Is low-level environmental mercury exposure of concern to human health Sci. Total Environ. 2009, 408 (2) 171-82
15. Virtanen, J.; Rissanen, T.; Voutilainen, S.; Tuomainen, T. Mercury as a risk factor for cardiovascular disease Journal of Nutritional Biochemistry 2007, 18, 75-85
16. Schober, S, S. T.; Jones, R. Blood Mercury Levels in Young Children and Childbearing-Aged Women- United States, 1999 - 2002 Journal of the American Medical Association [Online], 2003, p. 1667 - 74. http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5343a5.htm.
17. Hebestreit, H. Proteomics: an holistic analysis of nature's proteins Current Opinions in Pharmacology 2001, 1, 513-520
18. Twyman, R. M., Principles of Proteomics.: Garland Science/BIOS Scientific: New York, N.Y., 2004; p 241.
19. Bar, C.; Patil, R.; Doshi, J.; Kulkarni, M. J.; Gade, W. N. Characterization of the proteins of bacterial strain isolated from contaminated site involved in heavy metal resistance - a proteomic approach J. Biotechnol. 2007, 128 (3) 444-51
20. Qian, Y.; Harris, E. D.; Zheng, Y.; Tiffany-Castiglioni, E. Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells Toxicol. Appl. Pharmacol. 2000, 163 (3) 260-6
21. Witzmann, F. A.; Fultz, C. D.; Grant, R. A.; Wright, L. S.; Kornguth, S. E.; Siegel, F. L. Regional protein alterations in rat kidneys induced by lead exposure Electrophoresis 1999, 20 (4-5) 943-51
22. Neal, R.; Aykin-Burns, N.; Ercal, N.; Zigler, J. S., Jr. Pb2+ exposure alters the lens alpha A-Crystallin protein profile in vivo and induces cataract formation in lens organ culture Toxicology 2005, 212 (1) 1-9
23. Toraason, M.; Moorman, W.; Mathias, P. I.; Fultz, C.; Witzmann, F. Two-dimensional electrophoretic analysis of myocardial proteins from lead-exposed rabbits Electrophoresis 1997, 18 (15) 2978-82
24. Zhai, R.; Su, S.; Lu, X.; Liao, R.; Ge, X.; He, M.; Huang, Y.; Mai, S.; Lu, X.; Christiani, D. Proteomic profiling in the sera of workers ocupationally exposed to arsenic and lead: identification of potential biomarkers BioMetals 2005, 18, 603-613
25. Fanous, A.; Weiss, W.; Gorg, A.; Jacob, F.; Parlar, H. A proteome analysis of the cadmium and mercury response in Corynebacterium glutamicum Proteomics 2008, 8 (23-24) 4976-86
26. Vendrell, I.; Carrascal, M.; Vilaro, M. T.; Abian, J.; Rodriguez-Farre, E.; Sunol, C. Cell viability and proteomic analysis in cultured neurons exposed to methylmercury Hum Exp Toxicol 2007, 26 (4) 263-72
27. Vendrell, I.; Carrascal, M.; Campos, F.; Abian, J.; Sunol, C., Methylmercury disrupts the balance between phosphorylated and non-phosphorylated cofilin in primary cultures of mice cerebellar granule cells. A proteomic study. Toxicol. Appl. Pharmacol. epub 2009/10/06, 242 (1), 109 - 18.
28. McKelvey, W.; Gwynn, R.; Jeffery, N.; Kass, D.; Thorpe, L.; Garg, R.; Palmer, C.; Parsons, P. A Biomonitoring Study of Lead, Cadmium, and Mercury in the Blood of New York City Adults Environ. Health Perspect. 2007, 115 (10) 1435-1441
29. Palmer, C.; Lewis, M.; Geraghty, C.; Barbosa, F.; Parsons, P. Determination of lead, cadmium and mercury in blood for assessment of environmental exposure: A comparison between inductively coupled plasma-mass spectrometry and atomic absorption spectrometry Spectrochimica Acta Part B 2006, 61, 980-990
30. Anderson, L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease Journal of Physiology 2005, 563 (1) 23-60
31. Chich, J.; David, O.; Villers, F.; Schaeffer, B.; Lutomski, D. Statistics for proteomics: Experimental design and 2-DE differential analysis Journal of Chromatography B 2007, 849, 261-272
32. Inc., S. I. SAS, 9.1.3 Service Pack 4; SAS Institute Inc.: Cary, NC, 2002-2003.
33. Pellis, L.; Nicole, L.; Franssen-Van, H.; Burema, J.; Keijer, J. The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments Physiological Genomics 2003, 16, 99-106
34. Ewout, W.; Harrell, F., Jr., Statistical models for prognostication In: Symptom research: Methods and Opportunities. Bethesda: National Institutes of Health, 2009.
35. Babyak, D. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models Psychosomatic Medicine 2004, 66, 411-421
36. Rodriguez-Pineiro, A.; Rodriguez-Berrocal, F.; Cadena, M. Improvements in the search for potential biomarkers by proteomics: Application of principal component and discriminant analyses for two-dimensional maps evaluation Journal of Chromatography B 2007, 849, 251-260
37. MacKinnon, D.; Krull, J.; Lockwood, C. Equivalence of the Mediation, Confounding and Suppression Effect Prevention Science 2000, 1 (4) 173-181
38. Perneger, T. V. What's wrong with Bonferroni adjustments BMJ 1998, 316 (7139) 1236-8
39. Zubarev, R.; Mann, M. On the Proper Use of Mass Accuracy in Proteomics Molecular & Cellular Proteomics 2007, 6 (3) 377-381
40. Dodds, E.; Clowers, B.; Hagerman, P.; Lebrilla, C. Systematic characterization of high mass accuracy influence on false discovery and probability scoring in peptide mass fingerprinting Anal. Biochem. 2008, 372, 156-166
41. Olsen, J.; de Godoy, L.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap Molecular & Cellular Proteomics 2005, 4 (12) 2010-2021
42. Mann, B.; Madera, M.; Sheng, Q.; Tang, H.; Mechref, Y.; Novotny, M. ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics Rapid communications in mass spectrometry 2008, 22, 3823-3834
43. Omenn, G.; States, D.; Adamski, M.; Blackwell, T.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B.; Simpson, R.; Eddes, J.; Kapp, E.; Moritz, R.; Chan, D.; Rai, A.; Admon, A.; Aebersold, R.; Eng, J.; JHancock, W.; Hefta, S.; Meyer, H.; Paik, Y.; Yoo, J.; Ping, P.; Punds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D.; Hanash, S. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database Proteomics 2005, 5, 3226-3245
44. Hollingshead, A. B., Four Factor Index of Social Status. In Yale University, New Haven, CT, 1975.
45. Gump, B. B.; Reihman, J.; Stewart, P.; Lonky, E.; Darvill, T. Terrorism and cardiovascular responses to acute stress in children Health Psychol 2005, 24 (6) 594-600
46. Blood mercury levels in young children and childbearing-aged women-United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2004, 53 (43), 1018 - 20.
47. Van Slyke, D.; Hiller, A.; Phillips, R.; Hamilton, B.; Dole, V.; Archibald, R.; Eder, H. The estimation of plasma protein concentration from plasma specific gravity J. Biol. Chem. 1949, 331-347
48. Anderson, N.; Anderson, L. The Human Plasma Proteome Molecular & Cellular Proteomics 2002, 1, 845-867
49. Eravci, M.; Fuxius, S.; Broedel, O.; Weist, S.; Eravci, S.; Mansmann, U.; Schluter, H.; Tiemann, J.; Baumgartner, A. Improved comparitive proteome analysis based on two-dimensional gel electrophoresis Proteomics 2007, 7, 513-523
50. Hatters, D.; Peters-Libey, C.; Weisgraber, K. Apolipoprotein E structure: insights into function TRENDS in Biochemical Sciences 2006, 31 (8) 445-454
51. Eichner, J. E.; Dunn, S. T.; Perveen, G.; Thompson, D. M.; Stewart, K. E.; Stroehla, B. C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review Am J Epidemiol 2002, 155 (6) 487-95
52. Shih, R. A.; Hu, H.; Weisskopf, M. G.; Schwartz, B. S. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead Environ Health Perspect 2007, 115 (3) 483-92
53. Stewart, W. F.; Schwartz, B. S.; Simon, D.; Kelsey, K.; Todd, A. C. ApoE genotype, past adult lead exposure, and neurobehavioral function Environ Health Perspect 2002, 110 (5) 501-5
54. Godfrey, M. E.; Wojcik, D. P.; Krone, C. A. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity J Alzheimers Dis 2003, 5 (3) 189-95
55. Siest, G.; Bertrand, P.; Qin, B.; Herbeth, B.; Serot, J. M.; Masana, L.; Ribalta, J.; Passmore, A. P.; Evans, A.; Ferrari, M.; Franceschi, M.; Shepherd, J.; Cuchel, M.; Beisiegel, U.; Zuchowsky, K.; Rukavina, A. S.; Sertic, J.; Stojanov, M.; Kostic, V.; Mitrevski, A.; Petrova, V.; Sass, C.; Merched, A.; Salonen, J. T.; Tiret, L.; Visvikis, S. Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group Clin Chem Lab Med 2000, 38 (8) 721-30
56. Hatters, D. M.; Peters-Libeu, C. A.; Weisgraber, K. H. Apolipoprotein E structure: insights into function Trends Biochem. Sci. 2006, 31 (8) 445-54
57. Elliott, D. A.; Halliday, G. M.; Garner, B., Apolipoprotein-E forms dimers in human frontal cortex and hippocampus. BMC Neurosci 11, 23.
58. Wright, R. O.; Hu, H.; Silverman, E. K.; Tsaih, S. W.; Schwartz, J.; Bellinger, D.; Palazuelos, E.; Weiss, S. T.; Hernandez-Avila, M. Apolipoprotein E genotype predicts 24-month bayley scales infant development score Pediatr. Res. 2003, 54 (6) 819-25
59. Quaye, I. Haptoglobin, inflammation and disease Transactions of the Royal Society of Tropical Medicine and Hygiene 2008, 102, 735-742
60. Shor, M.; Boaz, M.; Gavish, D.; Wainshtein, J.; Matas, Z.; Shargorodsky, M. Relation of Haptoglobin Phenotype to Early Vascular Changes in Patients With Diabetes Mellitus American Journal of Cardiology 2007, 100, 1767-1770
61. Levy, A.; Hochberg, I.; Jablonski, K.; Resnick, H.; Lee, E.; Best, L.; Howard, B. Haptoglobin Phenotype Is an Independent Risk Factor for Cardiovascular Disease in Individuals With Diabetes: The Strong Heart Study Journal of the American College of Cardiology 2002, 40 (11) 1984-1990
62. Shan, J.; Baguinon, M.; Zheng, L.; Krishnamoorthi, R. Expression, refolding, and activation of the catalytic domain of human blood coagulation factor XII Protein Expression and Purification 2003, 27, 143-149
63. Miller, G.; Esnouf, M.; Burgess, A.; Cooper, J.; J., M. Risk of Coronary Heart Disease and Activation of Factor XII in Middle-Aged Men Arteriosclerosis, Thrombosis, and Vascualr Biology 1997, 17, 2103-2106
64. Zito, F.; Lowe, G.; Rumley, A.; McMahon, A.; Humphries, E. Association of the factor XII 46 > T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study Atherosclerosis 2002, 165, 153-158
65. Stanley, K.; Kocher, H.; Luzio, J.; Jackson, P.; Tschopp, J.; Dickson, J. The sequence and topology of human complement component C9 The EMBO Journal 1985, 4 (2) 375-382
66. Sherwood, L., Human Physiology From Cells to Systems. 6 ed.; Thomson Brooks/Cole: Belmont, C.A., 2007.
67. Eriksson, U.; Penninger, J.; Kopf, M. Mechanisms of autoimmune heart disease Drug Discovery Today: Disease Mechanisms 2004, 1 (3) 283-288
68. Eriksson, U.; Kopf, M.; Afanasyeva, M.; Penninger, J. Models of autoimmune heart disease Drug Discovery Today: Disease Mechanisms 2004, 1 (4) 411-416
69. Doherty, N.; Littman, B.; Reilly, K.; Swindell, A.; Buss, J.; Anderson, N. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis Electrophoresis 1998, 19, 355-363
70. Thomas, P.; Fenech, M. A review of genome mutation and Alzheimer's disease Mutagenesis 2007, 22 (1) 15-33
71. Basha, M. R.; Wei, W.; Bakheet, S. A.; Benitez, N.; Siddiqi, H. K.; Ge, Y. W.; Lahiri, D. K.; Zawia, N. H. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain J. Neurosci. 2005, 25 (4) 823-9
72. Bolin, C. M.; Basha, R.; Cox, D.; Zawia, N. H.; Maloney, B.; Lahiri, D. K.; Cardozo-Pelaez, F. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain FASEB J 2006, 20 (6) 788-90
73. Wu, J.; Basha, M. R.; Brock, B.; Cox, D. P.; Cardozo-Pelaez, F.; McPherson, C. A.; Harry, J.; Rice, D. C.; Maloney, B.; Chen, D.; Lahiri, D. K.; Zawia, N. H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD J. Neurosci. 2008, 28 (1) 3-9
74. Slooter, A. J.; de Knijff, P.; Hofman, A.; Cruts, M.; Breteler, M. M.; Van Broeckhoven, C.; Havekes, L. M.; van Duijn, C. M. Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study Neurosci. Lett. 1998, 248 (1) 21-4
75. Panza, F.; D'Introno, A.; Colacicco, A. M.; Capurso, C.; Pichichero, G.; Capurso, S. A.; Capurso, A.; Solfrizzi, V. Lipid metabolism in cognitive decline and dementia Brain Res Rev 2006, 51 (2) 275-92
76. Goldberg, G.; Bruns, G.; Rits, M.; Edge, M.; Kwiatkowski, D.; Human complement Factor, I. Analysis of cDNA-derived Primary Structure and Assignment of Its Gene to Chromosome 4 J. Biol. Chem. 1987, 262 (21) 10065-10071
77. Lachmann, P.; Muller-Eberhard, H. The Demonstration in Human Serum of "Conglutinogen-Activating Factor" and its Effect on the Third Component of Complement The Journal of Immunology 1968, 100, 691-698
78. Choi, A.; Weihe, P.; Budtz, J.; Jorgensen, P.; Salonen, J.; Tuomainen, T.; Murata, K.; Nielsen, H.; Petersen, M.; Askham, J.; Grandjean, P. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men Environmental Helath Perspectives 2008, 3, 367-372
79. Drayna, D.; Fielding, C.; Mclean, J.; Baer, B.; Castro, G.; Chen, E.; Comstock, L.; Henzel, W.; Kohr, W.; Rhee, L.; Wion, K.; Lawn, R. Cloning and Expression of Human Apolipoprotein D cDNA J. Biol. Chem. 1986, 261 (35) 16535-16539
80. Nakamura, K.; Yamagishi, S.; Matsui, T.; Yoshida, T.; Takenaka, K.; Jinnouchi, Y.; Yoshida, Y.; Ueda, S.; Adachi, H.; Imaizumi, T. Pigment Epithelium-Derived Factor Inhibits Neointimal Hyperplasia after Vascular Injury by Blocking NADPH Oxidase-Mediated Reactive Oxygen Species Generation The American Journal of Pathology 2007, 170 (6) 2159-2170
81. Janszky, I.; Hallqvist, J.; Ljung, R.; Hammar, N. Insulin-like growth factor binding protein-1 is a long-term predictor of heart failure in survivors of a first acute myocardial infarction and population controls International Journal of Cardiology [Online], September 14, 2008, p. 6. < http://dx.doi.org/10.1016/j.ijcard.2008.08.003 > (accessed April 12, 2009).
82. Engstrom, G.; Hedblad, B.; Tyden, P.; Lindgarde, F. Inflammation- sensitive plasma proteins are associated with increased incidence of heart failure: A population-based cohort study Atherosclerosis 2009, 202, 617-622
83. Engstrom, G.; Hedblad, B.; Janzon, L.; Lindgarde, F. Long-Term Change in Cholesterol in Relation to Inflammation-Sensitive Plasma Proteins: A longitudinal Study Ann Epidemiol 2007, 17, 57-63
84. Ebana, Y.; Ozaki, K.; Inoue, K.; Sato, H.; Iida, A.; Lwin, H.; Saito, S.; Mizuno, H.; Takahashi, A.; Nakamura, T.; Miyamoto, Y.; Ikegawa, S.; Odashiro, K.; Nobuyoshi, M.; Kamatani, N.; Hori, M.; Isobe, M.; Nakamura, Y.; Tanaka, T. A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction Journal of human genetics 2007, 52 (3) 220-229
85. Bucki, R.; Levental, I.; Kulakowska, A.; Janmey, P. Plasma gelsolin: function, prognostic value, and potential therapeutic use Current protein & peptide science 2008, 9 (6) 541-551
86. Li, G.; Shi, Y.; Chen, Y.; Sun, M.; Sader, S.; Maekawa, Y.; Arab, S.; Dawood, F.; Chen, M.; De Couto, G.; Liu, Y.; Fukuoka, M.; Yang, S.; Da Shi, M.; Kirshenbaum, L.; McCulloch, C.; Liu, P. Gelsolin Regulates Cardiac Remodeling After Myocardial Infarction Through DNase I-Mediated Apoptosis Circ. Res. [Online], February 26, 2009. (accessed April 13, 2009).
87. Rathinavel, A.; Dhandapany, P.; Annapoorani, P.; Ramasamy, S.; Selvam, G. Cardiac idoform of alpha-2 macroglobulin as a novel diagnostic marker for cardiac diseases European Journal of Cardiovascular Prevention and Rehabilitation 2005, 12 (6) 601-603
88. Kakkar, P.; Jaffery, F. Biological markers for metal toxicity Environmental Toxicology and Pharmacology 2005, 19, 335-349
89. Navas-Acien, A.; Guallar, E.; Silbergeld, E.; Rothenberg, S. Lead Exposure and Cardiovascular Disease-A Systematic Review Environ. Health Perspect. 2007, 115 (3) 472-484